Asia Pacific Anti-Viral Therapies Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (Generic Drugs and Branded Drugs), Mechanism of Action (Nucleotide Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, and Others), and Application (HIV, Hepatitis, Virus Influenza, Herpes, and Other Applications), and Country
Market Introduction
Antiviral therapy is one of the most exciting branches of virology. These therapies are based on several strategies—direct-acting antivirals target viral proteins, enzymes, or nucleic acids; passive antibodies neutralize circulating viruses; and several other antivirals target cellular proteins or processes essential for viral replication.
Get more information on this report :
Market Overview and Dynamics
The Asia Pacific anti-viral therapies market is expected to reach US$ 16,118.52 million by 2027 from US$ 8,135.93 million in 2019; it is anticipated to grow at a CAGR of 9.0% during 2020–2027.The growth of the market is attributed to the increasing prevalence of viral diseases and outbreak of COVID-19 pandemic, growing R&D expenditures of pharmaceutical companies, and rising government support for research activities and clinical trials. However, high cost of drug development obstructs the growth of the market to a certain extent.
Key Market Segments
In terms of type, the branded drugs segment accounted for a larger share of the Asia Pacific anti-viral therapies market in 2019. In terms of mechanism of action, the nucleotide polymerase inhibitors segment accounted for the largest share of the market in 2019. In terms of application, the HIV segment accounted for the largest share of the Asia Pacific anti-viral therapies market in 2019.
Major Sources and Companies Listed
Several major primary and secondary sources associated with the Asia Pacific anti-viral therapies market report are the World Health Organization (WHO), International Society for Pharmaceutical Engineering, China Food and Drug Administration (CFDA), National Health Commission (NHC) of China, India Brand Equity Foundation (IBEF), and others.
Reasons to Buy Report
- It provides understanding of the Asia Pacific, anti-viral therapies market landscape and identifies anti-viral therapies market segments that are most likely to guarantee a strong return.
- It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the Asia Pacific anti-viral therapies market.
- It helps efficiently plan merger and acquisition, and partnership deals in the anti-viral therapiesmarket by identifying market segments with the most promising probable sales
- It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of anti-viral therapies market performance of various segments pertaining to the Asia Pacificanti-viral therapies market.
- It provides anti-viral therapies market revenue forecast of the market based on various segments for the period from 2019 to 2027.
ASIA PACIFIC ANTI-VIRAL THERAPIESMARKET SEGMENTATION
By Type
- Branded Drugs
- Generic Drugs
By Mechanism of Action
- Nucleotide Polymerase Inhibitors
- Reverse Transcriptase Inhibitors
- Protease Inhibitors
- Others
By Application
- HIV
- Hepatitis
- Virus Influenza
- Herpes
- Others
By Country
- China
- Japan
- India
- South Korea
- Australia
Company Profiles
- Aurobindo Pharma Ltd
- AbbVie Inc.
- GlaxoSmithKline plc
- AstraZeneca
- F. HOFFMANN-LA ROCHE LTD
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Anti-viral therapies Market – By Type
1.3.2 Asia Pacific Anti-Viral Therapies Market – By Mechanism of Action
1.3.3 Asia Pacific Anti-Viral Therapies Market– By Application
1.3.4 Asia Pacific Anti-Viral Therapies Market – By Country
2. Asia Pacific Anti-Viral Therapies Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Anti-Viral Therapies Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Anti-Viral Therapies Market – Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Anti-Viral Therapies Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing R&D Expenditures in Pharmaceutical Companies
5.1.2 Rising Government Support for Research Activities and Clinical Trials
5.2 Market Restraints
5.2.1 High Cost of Drug Development
5.3 Market Opportunities
5.3.1 Emerging Markets
5.4 Future Trends
5.4.1 Growing Emphasis on Launching Anti-Viral Agents
5.5 Impact analysis
6. Anti-Viral Therapies Market – Asia Pacific Analysis
6.1 Asia Pacific Anti-Viral Therapies Market Revenue Forecasts and Analysis
7. Asia Pacific Anti-Viral Therapies Market Analysis and Forecasts To 2027 – By Type
7.1 Overview
7.2 Asia Pacific Anti-Viral Therapies Market, By Type 2019 & 2027 (%)
7.2.1 Asia Pacific Anti-Viral Therapies Market Revenue and Forecasts to 2027, By Type (US$ Mn)
7.3 Generic Drugs
7.3.1 Overview
7.3.2 Asia Pacific Generic Drugs Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Branded Drugs
7.4.1 Overview
7.4.1.1 Asia Pacific Branded Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
8. Asia Pacific Anti-Viral Therapies Market Analysis – By Mechanism of Action
8.1 Overview
8.2 Asia Pacific Anti-Viral Therapies Market, By Mechanism of Action 2019-2027 (%)
8.2.1 Asia Pacific Anti-Viral Therapies Market Revenue and Forecasts to 2027, By Mechanism of Action (US$ Mn)
8.3 Nucleotide Polymerase Inhibitor
8.3.1 Overview
8.3.2 Asia Pacific Nucleotide Polymerase Inhibitor Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Reverse Transcriptase Inhibitors
8.4.1 Overview
8.4.2 Asia Pacific Reverse Transcriptase Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Protease Inhibitors
8.5.1 Overview
8.5.2 Asia Pacific Protease Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Others
8.6.1 Overview
8.6.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. Asia Pacific Anti-Viral Therapies Market Analysis and Forecasts To 2027 – By Application
9.1 Overview
9.2 Asia Pacific Anti-Viral Therapies Market, By Application 2019 & 2027 (%)
9.2.1 Asia Pacific Anti-Viral Therapies Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.3 HIV
9.3.1 Overview
9.3.2 Asia Pacific HIV Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Hepatitis
9.4.1 Overview
9.4.2 Asia Pacific Hepatitis Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Herpes
9.5.1 Overview
9.5.2 Asia Pacific Herpes Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Influenza
9.6.1 Overview
9.6.2 Asia Pacific Influenza Market Revenue and Forecasts to 2027 (US$ Mn)
9.7 Other Applications
9.7.1 Overview
9.7.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
10. Anti-Viral Therapies Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 Asia Pacific Anti-Viral Therapies Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 Asia Pacific: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.3 Asia Pacific: Anti-Viral Therapies Market, by Type, 2018–2027 (USD Million)
10.1.4 Asia Pacific: Anti-Viral Therapies Market, by Mechanism of Action, 2018–2027 (USD Million)
10.1.5 Asia Pacific: Anti-Viral Therapies Market, by Application, 2018–2027 (USD Million)
10.1.6 Asia Pacific: Anti-Viral Therapies Market, by Country, 2019 & 2027 (%)
10.1.7 China: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 China: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 China: Anti-Viral Therapies Market, by Type, 2018–2027 (USD Million)
10.1.7.3 China: Anti-Viral Therapies Market, by Mechanism of Action, 2018–2027 (USD Million)
10.1.7.4 China: Anti-Viral Therapies Market, by Application, 2018–2027 (USD Million)
10.1.8 Japan: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Japan: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Japan: Anti-Viral Therapies Market, by Type, 2018–2027 (USD Million)
10.1.8.3 Japan: Anti-Viral Therapies Market, by Mechanism of Action, 2018–2027 (USD Million)
10.1.8.4 Japan: Anti-Viral Therapies Market, by Application, 2018–2027 (USD Million)
10.1.9 India: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 India: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 India: Anti-Viral Therapies Market, by Type, 2018–2027 (USD Million)
10.1.9.3 India: Anti-Viral Therapies Market, by Mechanism of Action, 2018–2027 (USD Million)
10.1.9.4 India: Anti-Viral Therapies Market, by Application, 2018–2027 (USD Million)
10.1.10 South Korea: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.1 South Korea: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.2 South Korea: Anti-Viral Therapies Market, by Type, 2018–2027 (USD Million)
10.1.10.3 South Korea: Anti-Viral Therapies Market, by Mechanism of Action, 2018–2027 (USD Million)
10.1.10.4 South Korea: Anti-Viral Therapies Market, by Application, 2018–2027 (USD Million)
10.1.11 Australia: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.1 Australia: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.2 Australia: Anti-Viral Therapies Market, by Type, 2018–2027 (USD Million)
10.1.11.3 Australia: Anti-Viral Therapies Market, by Mechanism of Action, 2018–2027 (USD Million)
10.1.11.4 Australia: Anti-Viral Therapies Market, by Application, 2018–2027 (USD Million)
11. Impact of COVID-19 Pandemic on Asia Pacific Anti-viral therapies Market
11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 Aurobindo Pharma Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 GlaxoSmithKline plc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 AstraZeneca
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 F. HOFFMANN-LA ROCHE LTD.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 AbbVie Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Anti-Viral Therapies Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 2. Asia Pacific Anti-Viral Therapies Market Revenue and Forecasts To 2027, By Mechanism of Action (US$ Mn)
Table 3. Asia Pacific Anti-Viral Therapies Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 4. Asia Pacific Anti-Viral Therapies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 5. Asia Pacific Anti-Viral Therapies Market, by Mechanism of Action – Revenue and Forecast to 2027 (USD Million)
Table 6. Asia Pacific Anti-Viral Therapies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 7. China Anti-Viral Therapies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 8. China Anti-Viral Therapies Market, by Mechanism of Action– Revenue and Forecast to 2027 (USD Million)
Table 9. China Anti-Viral Therapies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 10. Japan Anti-Viral Therapies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 11. Japan Anti-Viral Therapies Market, by Mechanism of Action– Revenue and Forecast to 2027 (USD Million)
Table 12. Japan Anti-Viral Therapies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 13. India Anti-Viral Therapies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 14. India Anti-Viral Therapies Market, by Mechanism of Action– Revenue and Forecast to 2027 (USD Million)
Table 15. India Anti-Viral Therapies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 16. South Korea Anti-Viral Therapies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 17. South Korea Anti-Viral Therapies Market, by Mechanism of Action– Revenue and Forecast to 2027 (USD Million)
Table 18. South Korea Anti-Viral Therapies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 19. Australia Anti-Viral Therapies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 20. Australia Anti-Viral Therapies Market, by Mechanism of Action– Revenue and Forecast to 2027 (USD Million)
Table 21. Australia Anti-Viral Therapies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 22. Glossary of Terms, Anti-Viral Therapies Market
LIST OF FIGURES
Figure 1. Anti-Viral Therapies Market Segmentation
Figure 2. Asia Pacific Anti-Viral Therapies Market Overview
Figure 3. Branded Drugs Segment Held Largest Share of Anti-Viral Therapies Market
Figure 4. China is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Asia Pacific Anti-Viral Therapies Market - Leading Country Markets (US$ Mn)
Figure 6. Anti-Viral Therapies Market – Asia Pacific PEST Analysis
Figure 7. Anti-Viral Therapies Market Impact Analysis of Driver and Restraints
Figure 8. Asia Pacific Anti-viral therapies Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. Asia Pacific Anti-Viral Therapies Market, By Type 2019 & 2027 (%)
Figure 10. Asia Pacific Generic Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. Asia Pacific Branded Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Asia Pacific Anti-Viral Therapies Market, by Mechanism of Action 2019 & 2027 (%)
Figure 13. Asia Pacific Nucleotide Polymerase Inhibitor Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. Asia Pacific Reverse Transcriptase Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. Asia Pacific Protease Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. Asia Pacific Anti-Viral Therapies Market, By Application 2019 & 2027 (%)
Figure 18. Asia Pacific HIV Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. Asia Pacific Hepatitis Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Asia Pacific Herpes Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Asia Pacific Influenza Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Asia Pacific: Anti-Viral Therapies Market, by Key Country – Revenue (2019) (USD Million)
Figure 24. Asia Pacific Anti-Viral Therapies Market Revenue and Forecast to 2027 (USD Million)
Figure 25. China: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 26. Japan: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 27. India: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. South Korea: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. Australia: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
The List of Companies - Asia Pacific Anti-Viral Therapies Market
- Aurobindo Pharma Ltd
- AbbVie Inc.
- GlaxoSmithKline plc
- AstraZeneca
- F. HOFFMANN-LA ROCHE LTD
- It provides understanding of the Asia Pacific, anti-viral therapies market landscape and identifies anti-viral therapies market segments that are most likely to guarantee a strong return.
- It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the Asia Pacific anti-viral therapies market.
- It helps efficiently plan merger and acquisition, and partnership deals in the anti-viral therapiesmarket by identifying market segments with the most promising probable sales.
- It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of anti-viral therapies market performance of various segments pertaining to the Asia Pacificanti-viral therapies market.
- It provides anti-viral therapies market revenue forecast of the market based on various segments for the period from 2019 to 2027.